Marjolein Homs

Marjolein Homs is a researcher at Erasmus MC in the Medical Oncology department. Her work focuses on pancreatic cancer, chemotherapy protocols, and clinical trial methodologies.

• Key Research Themes
  • Pancreatic Cancer Biomarkers
  • Hepatic Arterial Infusion Programs
  • Randomized Controlled Trials
  • Quality of Life in Oncology
  • Molecular Prognostication (KRAS, RNA subtyping)

Recent work includes blood sample optimization in PREOPANC-2 trials, nationwide quality-of-life studies in pancreatic cancer patients, and development of RNA-based prognostic models for metastatic disease. She collaborates extensively with the Dutch Pancreatic Cancer Group and international surgical oncology experts.